This innovative formulation is the result of a multi-year collaboration in which Naturmega contributed to the development, manufacturing, and supply of a specialised molecular matrix featuring EPA and DHA bonded to phospholipids rich in lysophosphatidylcholine (LPC), through its proprietary Ruby-O® technology platform.
The project highlights the versatility of Ruby-O® technology and Naturmega’s ability to work closely with strategic business partners in developing new and innovative formulations. Its contribution demonstrates how expertise in lipid science and the development of specialised molecular matrices can be integrated with complementary technologies to bring new solutions in advanced nutrition to market.
For Naturmega, this launch represents an important commercial milestone and reaffirms its commitment to scientific research, technological development, and global collaboration.
Naturmega congratulates the SourceOne Global Partners team and wishes them continued success with LysOmega, a highly innovative formulation that demonstrates the value of bringing together scientific expertise and technological capabilities to advance the next generation of nutritional solutions.
Smart Lipids. Real Science. Global Impact.
